Bone site-specific delivery of siRNA

Area of Science:

• Biomedical Engineering
• Nanotechnology
• Molecular Biology

Background:

• Small interfering RNAs (siRNA) show promise for treating bone disorders, including osteoporosis and bone metastases.
• Effective and specific in vivo delivery of siRNA to bone and bone-specific cells remains a significant challenge.
• Developing safe, efficient, and tissue/cell-specific delivery systems is essential to harness siRNA's therapeutic potential for bone diseases.

Purpose of the Study:

• To review recent advancements in bone site-specific delivery of siRNA at both tissue and cellular levels.
• To highlight bone-targeted nanoparticulate siRNA carriers and various targeting moieties.
• To discuss the application of these systems in preclinical models of osteoporosis and bone metastasis.

Main Methods:

• Review of literature on bone-targeted nanoparticulate siRNA carriers.
• Analysis of various bone-targeting moieties, including bisphosphonates, oligopeptides (Asp)8 and (AspSerSer)6, and aptamers.
• Examination of how these moieties enable specific targeting of bone sub-domains and cell types.

Main Results:

• Bone-targeted moieties incorporated into siRNA carriers facilitate recognition of specific bone sub-tissue domains and resident cell types.
• These systems enable targeted delivery to bone-formation surfaces, bone-resorption surfaces, or osteoblasts.
• Successful application demonstrated in preclinical models for osteoporosis and bone metastasis.

Conclusions:

• Nanoparticulate carriers functionalized with bone-seeking moieties represent a promising strategy for targeted siRNA delivery in bone disorders.
• This approach allows for precise targeting of specific bone cells and microenvironments, enhancing therapeutic efficacy.
• Further development of these targeted delivery systems is critical for advancing siRNA-based bone therapeutics.